Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer.
Clinical trial NCT04896320 · WITHDRAWN
Trial details
- NCT number
- NCT04896320
- Sponsor
- Providence Health & Services
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2023-06-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.